Correlation Between JETEMA and InnoTherapy
Can any of the company-specific risk be diversified away by investing in both JETEMA and InnoTherapy at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining JETEMA and InnoTherapy into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between JETEMA Co and InnoTherapy, you can compare the effects of market volatilities on JETEMA and InnoTherapy and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in JETEMA with a short position of InnoTherapy. Check out your portfolio center. Please also check ongoing floating volatility patterns of JETEMA and InnoTherapy.
Diversification Opportunities for JETEMA and InnoTherapy
-0.59 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between JETEMA and InnoTherapy is -0.59. Overlapping area represents the amount of risk that can be diversified away by holding JETEMA Co and InnoTherapy in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on InnoTherapy and JETEMA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on JETEMA Co are associated (or correlated) with InnoTherapy. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of InnoTherapy has no effect on the direction of JETEMA i.e., JETEMA and InnoTherapy go up and down completely randomly.
Pair Corralation between JETEMA and InnoTherapy
Assuming the 90 days trading horizon JETEMA Co is expected to generate 1.97 times more return on investment than InnoTherapy. However, JETEMA is 1.97 times more volatile than InnoTherapy. It trades about 0.09 of its potential returns per unit of risk. InnoTherapy is currently generating about -0.14 per unit of risk. If you would invest 1,697,000 in JETEMA Co on September 1, 2024 and sell it today you would earn a total of 252,000 from holding JETEMA Co or generate 14.85% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
JETEMA Co vs. InnoTherapy
Performance |
Timeline |
JETEMA |
InnoTherapy |
JETEMA and InnoTherapy Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with JETEMA and InnoTherapy
The main advantage of trading using opposite JETEMA and InnoTherapy positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if JETEMA position performs unexpectedly, InnoTherapy can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in InnoTherapy will offset losses from the drop in InnoTherapy's long position.JETEMA vs. Sam Yang Foods | JETEMA vs. Daiyang Metal Co | JETEMA vs. Sempio Foods Co | JETEMA vs. Songwon Industrial Co |
InnoTherapy vs. Kolon Life Science | InnoTherapy vs. JETEMA Co | InnoTherapy vs. Aminologics CoLtd | InnoTherapy vs. Daihan Pharmaceutical CoLtd |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
FinTech Suite Use AI to screen and filter profitable investment opportunities |